Patología neurológica en una unidad de cuidados intensivos pediátricos de tercer nivel. Evolución funcional. Nuestra experiencia by P. Madurga Revilla, J. López Pisón, P. Samper Villagrasa, J.P. García Íñiguez, R. Garcés Gómez, M. Domínguez Cajal, I. Gil Hernández

“…Neuromonitoring and neuroprotection measures and the evaluation of functional progression are necessary to improve critical child care.…”
Get full text

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation o... by Susan Ball, Jane Vickery, Jeremy Hobart, Dave Wright, Colin Green, James Shearer, Andrew Nunn, Mayam Gomez Cano, David MacManus, David Miller, Shahrukh Mallik, John Zajicek

“…The absence of disease-modifying treatments in progressive MS warrants further studies of the cannabinoid pathway in potential neuroprotection. Trial registration: Current Controlled Trials ISRCTN62942668. …”
Get full text

Selected Abstracts of the 1st Congress of joint European Neonatal Societies (jENS 2015); Budapest (Hungary); September 16-20, 2015; Session “Pharmacology” by --- Various Authors

“…PHARMACOKINETICS OF ANTENATAL MAGNESIUM SULFATE IN PRETERM INFANTS FOR NEUROPROTECTION • N. Merchant, A. Hawaa, A.D. Edwards, E. …”
Get full text

Selected Lectures of the 14th International Workshop on Neonatology; Cagliari (Italy); October 24th-27th, 2018 by --- Various Authors

“…Herting LECT 5. DRUGS AND NEUROPROTECTION • S. Perrone, E. Laschi, G. Nanni, G. …”
Get full text

DHEAS increases levels of GluR2/3 and GluR2, AMPA receptor subunits, in C57BL/6 mice hippocampus El DHEAS incrementa la expresión de GluR2/3 y GLUR2 del receptor AMPA en el hipocam... by Diego Sepúlveda Falla, Carolina Ospina Villegas, Alvaro Andrés Barrera Ocampo, Gloria Patricia Cardona Gómez

“…<p class="MsoNormal" style="text-align: justify; line-height: normal; margin: 0cm 0cm 0pt; mso-layout-grid-align: none;"><span style="font-family: ";Times New Roman";,";serif";; font-size: 12pt; mso-ansi-language: EN-US;" lang="EN-US">Dehydroepiandrosterone sulfate (DHEA-S) is a neurosteroid that has effects such as neuromodulator of synaptic transmission and neuroprotection. The specific signaling pathways for these effects are not elucidated yet. …”
Get full text

Psychopharmacology 2003 Conference, 10-13 September 2003 by Diana P Morrison, Andre F Joubert, Dave Swingler, Denise White, Joseph R Calabrese, Roger M Pinder, Donald W Black, David R Williams, David Castle, Dora Wynchank, Kerry Gibson, Helen Clark, Greg McCarthy, Alan J Flisher, Sebastian Akalula, James Warwick, Theophilus Lazarus, Frans Korb, Nandi Siegfried, Z Nthakwana, Petro Kempen, Eugene Allers, Alan St Clair Gibson, Mark Solms, Ruth Jarvis, Edward Nyatia, Joachim Uys, Amichand Dairam, H Maharaj, M Mabanda, Joseph R Calabrese

“…Can exercise provide Neuroprotection in a rat model for Parkinson's disease? …”
Get full text